Wilmington, DE6 Active Studies

Ankylosing Spondylitis Clinical Trials in Wilmington, DE

Find 6 actively recruiting ankylosing spondylitis clinical trials in Wilmington, DE. Connect with local research sites and explore new treatment options.

6
Active Trials
4
Sponsors
4,145
Enrolling

Recruiting Ankylosing Spondylitis Studies in Wilmington

About Ankylosing Spondylitis Clinical Trials in Wilmington

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 6 ankylosing spondylitis clinical trials recruiting participants in Wilmington, DE. These studies are seeking a combined 4,145 participants. Research is being sponsored by Children's Oncology Group, AstraZeneca, BioMarin Pharmaceutical and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Wilmington — FAQ

Are there ankylosing spondylitis clinical trials in Wilmington?

Yes, there are 6 ankylosing spondylitis clinical trials currently recruiting in Wilmington, DE. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Wilmington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Wilmington research site will contact you about next steps.

Are clinical trials in Wilmington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Wilmington studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 6 active trials in Wilmington are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 18, 2026 from ClinicalTrials.gov